Skip to main content
. 2013 Mar;95(2):118–124. doi: 10.1308/003588413X13511609957254

Table 6.

Detailed microbiology of infections

Patient number Causative organism Antibiotics used (length of course)
1 Coagulase-negative Staphylococcus and Enterococcus spp Meropenem and vancomycin (4 weeks), then metronidazole (4 weeks)
2 Staphylococcus aureus Rifampicin, metronidazole and clindamycin (2 weeks)
3 S aureus Rifampicin and flucloxacillin (2 weeks), then doxycycline (6 weeks)
4 S aureus Rifampicin and flucloxacillin (7 weeks)
5 Skin flora only Vancomycin and rifampicin (2 weeks), then flucloxacillin and fusidic acid (2 weeks)
6 Coliform Rifampicin and clindamycin (9 weeks)
7 Proteus spp Flucloxacillin (3 weeks), then piperacillin/tazobactam (1 week), then vancomycin and rifampicin (2 weeks)
8 Coagulase-negative Staphylococcus Flucloxacillin (10 weeks)
9 S aureus Rifampicin and flucloxacillin (4 weeks)
10 MRSA Vancomycin, rifampicin, gentamicin, mupirocin and chlorhexidine (2 weeks), then doxycycline and rifampicin (4 weeks)
11 Coliform Meropenem (2 weeks), then ertapenem (5 weeks)
12 Enterococcus spp Flucloxacillin, amoxicillin (10 weeks) and gentamicin (first 2 weeks only)
13 Coliform and Klebsiella pneumoniae Rifampicin and flucloxacillin (6 weeks)
14 S aureus and Group A Streptococcus Co-amoxiclav (2 weeks)
15 MRSA and Enterococcus spp Flucloxacillin and gentamicin (2 weeks), then clindamycin (2 weeks), mupirocin and chlorhexidine (thoughout)
16 S aureus and Enterococcus spp Rifampicin, metronidazole and clindamycin (2 weeks)